Format

Send to

Choose Destination
Stroke. 2016 Dec;47(12):e269. Epub 2016 Nov 15.

Response by Steinberg et al to Letter Regarding Article, "Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2A Study".

Author information

1
Department of Neurosurgery Stanford University School of Medicine and Stanford Health Care, CA.
2
Department of Neurosurgery NYU Langone Medical Center New York, NY.
3
SanBio Inc Mountain View, CA.
PMID:
27895304
DOI:
10.1161/STROKEAHA.116.015209
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center